Observers say that while capping the cost of insulin at $35 a month benefits consumers, it doesn't strengthen Lilly's legal arguments since the company and others raised list prices by 150% over five years, alleges one lawsuit.

The demands being made on employees require that every organization to take virtual meetings and virtual training seriously today.

Many surgical procedures proved to be pricier for hospitals in the network.

Facing pressure to curb diabetes treatment costs, the price cut puts the drugmaker's insulin in line with the Inflation Reduction Act, which last month capped the medication's cost for seniors on Medicare.